Biomoda joins U.S. cancer research network
>Cancer diagnostics company Biomoda has been accepted as an associate member of the Early Detection Research Network (EDRN), an initiative of the National Cancer Institute
>Cancer diagnostics company Biomoda has been accepted as an associate member of the Early Detection Research Network (EDRN), an initiative of the National Cancer Institute
Ameritas Group, a division of Ameritas Life Insurance, has made a $250,000 gift commitment to the University of Nebraska Foundation to establish a permanent endowment
While the incidence of oropharyngeal cancer among some ethnic groups in the U.S. have declined, rates of human papillomavirus (HPV)-related oral cancer among white men
The incidence of squamous cell carcinoma of the tongue in young white women in the U.S. has risen steadily over the last three decades, according
DentalEZ Group has acquired all rights in the dental market to the Identafi 3000 Ultra optical diagnostic device from Trimira, a subsidiary of Remicalm, a
Dwight Pemberton, DDS, the dentist at the Veterans’ Affairs (VA) Medical Center in Dayton, OH, whose lax infection control practices potentially exposed hundreds of patients
Oral healthcare professionals can play an important role in preventing oral cancer by educating patients about oral cancer prevention strategies, including eating lots of fruits
The ADA along with nine major medical and public health groups has launched a campaign urging Major League Baseball (MLB) and the MLB Players Association
In a clinical study designed to detect human papillomavirus (HPV) E6/E7 mRNA in routine clinical specimens of head and neck cancer, HPV status determined by
Saint Louis University Cancer Center has received a $50,000 grant from the Lottie Caroline Hardy Charitable Trust to study a therapy that targets head and
Researchers at the Forsyth Institute have identified a new pathogen connected to severe early childhood caries (ECC). This research may offer the potential to intervene
Defining the minimum requirements for assigning a diagnosis of human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (SCC) is increasingly important for the head-and-neck oncology community,